Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
Abstract
To assess the value of annual serum neurofilament light (NfL) measures in predicting 10‐year clinical and MRI outcomes in multiple sclerosis (MS).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 16, 2018
- Source ID
- 10.1002/acn3.638
Entities
People
- Anu Paul
- Bonnie I Glanz
- Brian C. Healy
- Camilo Diaz‐cruz
- Christian Barro
- Cindy Gonzalez
- David Leppert
- Davorka Tomic
- Dieter Häring
- Harald Kropshofer
- Howard L. Weiner
- Isabelle V. Pierre
- Jens Kuhle
- Ludwig Kappos
- Mattia Rosso
- Neda Sattarnezhad
- Pia Kivisakk
- Rohit Bakshi
- Shrishti Saxena
- Tanuja Chitnis
- Zuzanna Michalak
Organizations
- Children Living with Inherited Metabolic Diseases
- Harvard Medical School
- Massachusetts General Hospital
- Novartis
- United States Department of Defense
- University of Basel